Nitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: Is there a connection?

Journal of Clinical Gastroenterology

Volumn 44, Issue 10, 2010, Pages 713-719

  Papadopoulos, Nikolaos ^a   Soultati, Aspasia ^b   Goritsas, Constantin ^c   Lazaropoulou, Christina ^d   Achimastos, Apostolos ^b   Adamopoulos, Adam ^b   Dourakis, Spyridon P ^b  

^a 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Department of Internal Medicine ^*  (Greece)

^d AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMMONIA; C REACTIVE PROTEIN; NITRIC OXIDE;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

AGED; AMMONIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GREECE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 77958506205     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181d47f71     Document Type: Article

References (40)

1. Frerichs FT. A Clinical Treatise on Diseases of the Liver. Vol 1. Translated by Murchison C. London: The New Sydenham Society; 1860:193-246.
2. Jones EA, Weissenborn K. Neurology and the liver. J Neurol Neurosurg Psychiatry. 1997;63:279-293.
3. Butterworth R. Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol. 2000;32 (suppl 1):171-180.
4. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalo-pathy\ definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716-721.
5. Basile AS, Jones EA. Ammonia and GABAergic neuro-transmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology. 1997;25:103-105.
6. Sherlock S, Summerskill WHJ, White LP, et al. Portal-systemic encephalopathy: neurological complications of liver disease. Lancet. 1954;267:453-457.
7. Hazell AS, Butterworth RF. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc Soc Exp Biol Med. 1999;222:99-112.
8. Szerb JC, Butterworth RF. Effect of ammonium ions on synaptic transmission in the mammalian central nervous system. Prog Neurobiol. 1992;39:135-153.
9. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase of rat brain. Brain Res. 1979;161:303-310.
10. Albrecht J, Dolinska M. Glutamine as a pathogenic factor in hepatic encephalopathy. J Neurol Res. 2001;65:1-5.
11. Palmer PMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature. 1988;333: 664-667.
12. Vemuganti L, Raghavendra R, Butterworth RF. Neuronal nitric oxide synthase and hepatic encephalopathy. Metab Brain Dis. 1998;13:175-189.
13. Mohammed NA, Abd E-Aleem SA, Appleton I, et al. Expression of nitric oxide synthase isoforms in human liver cirrhosis. J Pathol. 2003;200:647-655.
14. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet. 1991;337:778-779.
15. Gonzalez-Abraldes J, Garcia-Pagan JC, Bosch J. Nitric oxide and portal hypertension. Metab Brain Dis. 2002;17:311-324.
16. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepa-tology. 1994;20:1359-1363.
17. Janigro D, West GA, Nguyen TS, et al. regulation of blood-brain barrier endothelial cells by nitric oxide. Circ Res. 1994; 75:528-538.
18. Moshage H, Kok B, Huizenga R, et al. Nitrite and nitrate in plasma: a critical evaluation. Clin Chem. 1995;41/6:892-896.
19. Giovagnoli AR, Del Pesce M, Mascheroni S, et al. Trail Making Test: normative values from 287 normal adult controls. Ital J Neurol Sci. 1996;17:305-309.
20. Rikkers L, Jenko P, Rudman D, et al. Subclinical hepatic encephalopathy: detection, prevalence and relationship to nitrogen metabolism. Gastroenterology. 1978;75:462-469.
21. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy ambulant non-shunted patients with cirrhosis. J Hepatol. 1986;3:75-82.
22. Shawcross DL, Wright G, Damink SWMO, et al. Role of ammonia and inflammation in minimal hepatic encephalo-pathy. Metab Brain Dis. 2007;22:125-138.
23. Marchesini G, Zoli M, Dondi C et al. Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance. Dig Dis Sci. 1980;25:763-768.
24. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461-470.
25. Bomzon A, Blendis LM. The nitric oxide hypothesis ans the hyperdynamic circulation in cirrhosis. Hepatology. 1994;20: 1343-1350.
26. Vemuganti L, Raghavendra R. Nitric oxide in hepatic encephalopathy and hyperammonemia. Neurochem Int. 2002; 41:161-170.
27. Rao VLR, Audet RM, Butterworth RF. Increased nitric oxide synthase activities and L-(3H)arginine uptake in brain following portacaval anastomosis. J Neurochem. 1995;65:677-681.
28. Chu CJ, Chang CC, Wang TF, et al. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide\induced fulminant hepatic failure: role of nitric oxide synthase isoforms. J Gastroenterol Hepatol. 2006;21:1194-1199.
29. Heller J, Kristeleit H, Brensing K-A, et al. Nitrite and nitrate levels in patients with cirrhosis of the liver: influence of kidney function and fasting state. Scand J Gastroenterol. 1999;3: 297-302.
30. Genesca J, Gonzalez A, Segura R, et al. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol. 1999;94:169-177.
31. Hori N, Okanoue T, Mori T, et al. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis. Clin Exp Pharmacol Physiol. 1996;23:3035.
32. Guarner C, Soriano G, Tomas A, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology. 1993;5:1139-1143.
33. Mackenzie IMJ, Ekangaki A, Young D, et al. Effect of renal function on serum nitrogen oxide concentrations. Clin Chem. 1996;42:440-444.
34. Castillo L, DeRojas TC, Chapman TE, et al. Splachnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci USA. 1993;90:193-197.
35. Elsing C, Harenberg S, Stremmel W, et al. Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients. World J Gastroenterol. 2007;13:421-425.
36. Albillos A, De la Hera A, Gonzalez M, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology. 2003;37:208-217.
37. Chin-Dusting JP, Rasaratnam B, Jennings GL, et al. Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Ann Intern Med. 1997;127:985-988.
38. Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003;114:188-193.
39. Nicolao F, Efrati C, Masini A, et al. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol. 2003;38:441-446.
40. Sthal J. Studies of the blood ammonia in liver disease. Ann Intern Med. 1963;58:1-24.